Organic Process Research & Development · 2015 · 13 citations · 15 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoverySynthetic Medicinal ChemistryNatural Product Drug DiscoverySafer Chemical SynthesisAmination ReactionsCrystallizationMedicinal Chemistry ApplicationsPi3k InhibitorsPiperidine SynthesisProtecting Group ChemistryProtecting Group-free SynthesisSuzuki - Miyaura Coupling
We report a practical and protecting-group-free synthesis amenable to produce multikilogram amounts of PI3K/mTOR inhibitor GDC-0980 . The route employed metalation/formylation and reductive amination followed by a metal catalyzed Suzuki–Miyaura cross-coupling. The metalation was performed via triarylmagnesiate intermediates allowing formylation under noncryogenic conditions. 2-Picoline·BH 3 was employed to replace Na(OAc) 3 BH in the reductive amination and to eliminate the use of molecular sieves. A concise one-step synthesis was developed for the selective monoamidation of piperazine with ( S )-lactate to produce the piperazine lactamide starting material. The boronic acid was produced from 2-amino-5-bromopyrimidine in a one-step and protecting-group-free approach. The final crystallization in 1-propanol and water afforded the API in 59% overall yield in four steps and >99% purity by HPLC.
15
Sauveur-Michel Maira, Frédéric Stauffer, Josef Brueggen et al. · Molecular Cancer Therapeutics · 2008 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +13
Concepción Jiménez‐González, Peter Poechlauer, Quirinus B. Broxterman et al. · Organic Process Research & Development · 2011 · 421 citations
Engineering, Chemical Engineering, Manufacturing Engineering +17